
Camlin Fine Sciences Ltd is Rated Strong Sell
2026-11-21 10:10:19Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 21 November 2026, providing investors with the latest insights into its performance and prospects.
Read More
Camlin Fine Sciences Ltd is Rated Strong Sell
2026-11-10 10:10:16Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here are based on the company’s current position as of 10 November 2026, providing investors with the latest insights into its performance and prospects.
Read MoreCamlin Fine Sciences Falls 9.52% Amid Sharp Volatility and Valuation Risks
2026-11-08 12:00:11Key Events This Week 2 Nov: Intraday high surge to Rs.90.7 (+7.61%) 4 Nov: Sharp gap down and 52-week low at Rs.78.98 5 Nov: Steep 18.65% price decline to Rs.74.13 6 Nov: Week closes marginally lower at Rs.76.05 (-0.08%) Week OpenRs.84.05 Week CloseRs.76.05<div class="stat-change negative...
Read More
Camlin Fine Sciences Ltd Faces Heightened Valuation Risks Amid Steep Price Decline
2026-11-05 08:00:42Camlin Fine Sciences Ltd, a small-cap player in the Specialty Chemicals sector, has witnessed a significant deterioration in its valuation metrics alongside a sharp drop in its share price. The company’s price-to-earnings (P/E) ratio has plunged into negative territory, signalling mounting concerns over profitability and investor sentiment. This article analyses the recent valuation shifts, compares them with peer averages, and assesses the implications for investors amid a challenging market backdrop.
Read More
Five Consecutive Losses Push Camlin Fine Sciences Ltd to a New 52-Week Low
2026-11-04 10:41:36For the fifth consecutive session, Camlin Fine Sciences Ltd closed lower, hitting a fresh 52-week low of Rs 78.98 on 4 Nov 2026. This marks a steep decline of nearly 60% over the past year, sharply underperforming the Sensex’s modest 7.7% fall during the same period.
Read More
Camlin Fine Sciences Ltd Hits Intraday Low Amid Significant Price Pressure
2026-11-04 09:31:34Shares of Camlin Fine Sciences Ltd, a small-cap player in the Specialty Chemicals sector, declined sharply on 4 Nov 2026, hitting an intraday low of Rs 79.84, down 12.38% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and heightened volatility.
Read More
Camlin Fine Sciences Ltd Surges 7.61% to Day's High of Rs 90.7 — Outperforms Sector by 7.18 Percentage Points
2026-11-02 11:46:11The Sensex advanced 1.16% on 2 Nov 2026, yet Camlin Fine Sciences Ltd outpaced the broader market with a 7.61% gain, touching an intraday high of Rs 90.7. This 7.18 percentage-point outperformance over its Specialty Chemicals sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.
Read More
Camlin Fine Sciences Ltd is Rated Strong Sell
2026-10-28 10:10:25Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 28 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
13-Nov-2026 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 13 2026 for Ashish Subhash Dandekar
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
13-Nov-2026 | Source : BSEThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on November 13 2026 for Ashish Subhash Dandekar
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
09-Nov-2026 | Source : BSEThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on November 09 2026 for Ashish Subhash Dandekar
Corporate Actions
No Upcoming Board Meetings
Camlin Fine Sciences Ltd has declared 45% dividend, ex-date: 28 Jul 16
Camlin Fine Sciences Ltd has announced 1:2 stock split, ex-date: 04 Sep 14
No Bonus history available
Camlin Fine Sciences Ltd has announced 5:41 rights issue, ex-date: 08 Jan 25
